Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789892 | 0.91 | POLB (0.42) | SLC22A12GAAKDM4EHPGDHSD17B10 | |
| SCHEMBL210161 | 0.85 | PKM (0.42) | SLC22A12GAAHPGDMAPTPOLB | |
| Toluene SCHEMBL8907280 | 0.85 | L3MBTL1 (0.41) | SLC22A12GAAMAPTTDP1POLB | |
| Toluene SCHEMBL1159746 | 0.85 | L3MBTL1 (0.41) | SLC22A12GAAMAPTTDP1POLB | |
| Toluene SCHEMBL1079482 | 0.85 | L3MBTL1 (0.41) | SLC22A12GAAMAPTTDP1POLB | |
| Toluene SCHEMBL8994440 | 0.85 | L3MBTL1 (0.41) | SLC22A12GAAMAPTTDP1POLB | |
| SCHEMBL17424894 | 0.84 | SMN1; SMN2 (0.45) | SLC22A12GAAKDM4EHPGDHSD17B10 | |
| SCHEMBL658608 | 0.84 | KLKB1 (0.43) | SLC22A12GAAKDM4EHPGDHSD17B10 | |
| SCHEMBL20045097 | 0.81 | HPGD (0.50) | SLC22A12GAAKDM4EHPGDHSD17B10 | |
| SCHEMBL1223549 | 0.81 | CYP4F2 (0.42) | SLC22A12GAAKDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106243006-B | (3-alkylthio) acrylic acid derivative compound and cosmetic application thereof | 爱西美有限公司 | 2019-12-31 | — | — | CN | disclosed |
| US-9815783-B2 | (3-alkylthio)propenoic acid-derived compounds and their application in cosmetics | EXSYMOL (MC) | 2017-11-14 | — | — | US | disclosed |
| CN-106243006-A | (3 alkylthio group) acrylic acid derivative compound and cosmetic applications thereof | 爱西美有限公司 | 2016-12-21 | — | — | CN | disclosed |
| US-20160362364-A1 | (3-ALKYLTHIO)PROPENOIC ACID-DERIVED COMPOUNDS AND THEIR APPLICATION IN COSMETICS | EXSYMOL (MC) | 2016-12-15 | — | — | US | disclosed |
| US-8003686-B2 | Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives | DSM IP ASSETS B.V. (NL) | 2011-08-23 | — | — | US | disclosed |
| EP-2356986-A1 | COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME | Universitat Rovira I Virgili (ES) | 2011-08-17 | — | — | EP | disclosed |
| US-20100010232-A1 | Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives | DSM IP ASSETS B.V. (NL) | 2010-01-14 | — | — | US | disclosed |
| US-6121512-A | NUCLEOTIDE SEQUENCES WHICH CODE ENZYMATIC PROTEINS: FOR AMPLIFIED ABILITY OF PLANTS TO METABOLIZE PHENYLUREA COMPOUNDS | NORTH CAROLINA STATE UNIVERSITY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6117885-A | Biphenyl-substituted quinoline derivatives | E. R. SQUIBB & SONS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| WO-1999019493-A9 | CYTOCHROME P-450 CONSTRUCTS AND METHODS OF PRODUCING HERBICIDE-RESISTANT TRANSGENIC PLANTS | UNIV NORTH CAROLINA STATE (US) | 1999-08-05 | — | — | WO | disclosed |
| US-5374615-A | Treating hypertension and congestive heart failure, preventing cardiac hypertrophy | E. R. SQUIBB & SONS, INC. (US) | 1994-12-20 | — | — | US | disclosed |
| US-5312975-A | Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid | ZAMBON GROUP S.P.A. (IT) | 1994-05-17 | — | — | US | disclosed |
| EP-0556060-A1 | Biphenyl-substituted quinoline and naphthyridines derivatives as angiotensine II antagonists | E.R. SQUIBB & SONS, INC. (US) | 1993-08-18 | — | — | EP | disclosed |
| US-5225421-A | Leukotriene antagonists; cytoprotective agents | MERCK FROSST CANADA, INC. (CA) | 1993-07-06 | — | — | US | disclosed |
| EP-0501269-A1 | Imidazole and benzimidazole derivatives | E.R. SQUIBB & SONS, INC. (US) | 1992-09-02 | — | — | EP | disclosed |
| EP-0494419-A2 | Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid | ZAMBON GROUP S.p.A. (IT) | 1992-07-15 | — | — | EP | disclosed |
| EP-0488532-A1 | Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives | E.R. Squibb & Sons, Inc. (US) | 1992-06-03 | — | — | EP | disclosed |
| EP-0275667-B1 | 3-HETERO-SUBSTITUTED-N-BENZYL-INDOLES | MERCK FROSST CANADA INC. (CA) | 1992-03-18 | — | — | EP | disclosed |
| US-5081138-A | Antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents | MERCK FROSST CANADA, INC. (CA) | 1992-01-14 | — | — | US | disclosed |
| EP-0200960-A1 | Total estriol fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010232-A1 | Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives | AADAC, ARNT, PIGS | SLC22A12 1830/4885GAA 2782/4885KDM4E 124/4885 |
| US-20160362364-A1 | (3-ALKYLTHIO)PROPENOIC ACID-DERIVED COMPOUNDS AND THEIR APPLICATION IN COSMETICS | ALOX12, ALOX15B, ALOX15 | SLC22A12 4218/4885GAA 3290/4885KDM4E 1961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.